Categories: Healthcare

Global Conjunctivitis Treatment Market Growth Analysis 2024 – Forecast Market Size And Key Factors Driving Growth

Close up shot of female pours drops in red eye, has conjuctivitis or glaucoma, bad eyesight and pain. Eyes pain treatment concept. Woman cures red blood eye

Overview and Scope

Conjunctivitis treatment refers to the medical interventions and therapies to manage and resolve the symptoms and underlying causes of conjunctivitis, also known as pink eye. It involves using various medications to reduce inflammation, relieve symptoms, and prevent the spread of the infection.

Sizing and Forecast

The conjunctivitis treatment market size has grown steadily in recent years. It will grow from $4.49 billion in 2023 to $4.7 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to globalization of eye care services, increased affordability and accessibility, demand for combination therapies, innovation in anti-inflammatory treatments, growth in eye care infrastructure..

The conjunctivitis treatment market size is expected to see steady growth in the next few years. It will grow to $5.48 billion in 2028 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to focus on preventive healthcare, rise in global incidence of conjunctivitis, growth in healthcare awareness and access, increase in environmental allergens, expanding aging population.. Major trends in the forecast period include regulatory shifts in treatment approvals, focus on comfort and symptom management, integration of artificial intelligence in diagnosis, demand for combination therapies, growth in herbal and alternative remedies..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/conjunctivitis-treatment-global-market-report

Segmentation & Regional Insights
The conjunctivitis treatment market covered in this report is segmented –

1) By Drug Class: Antibiotics, Antiviral, Anti-Allergic, Artificial Tears
2) By Disease Type: Allergic Conjunctivitis, Bacterial Conjunctivitis, Viral Conjunctivitis
3) By Route Of Administration: Oral, Topical
4) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

North America was the largest region in the conjunctivitis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the conjunctivitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12051&type=smp

Major Driver Impacting Market Growth

The rising prevalence of conjunctivitis cases is expected to propel the growth of the conjunctivitis treatment market going forward. Conjunctivitis refers to the inflammation of the conjunctiva, the thin, clear tissue that covers the white part of the eye and lines the inner surface of the eyelids. The growth of the conjunctivitis treatment market is driven by the increased demand for treatment options as more individuals seek medical attention and treatment due to the rising prevalence of conjunctivitis. For instance, in June 2022, according to the American Medical Association, a US-based professional association, the prevalence of viral conjunctivitis was found to be higher than bacterial conjunctivitis among adults, accounting for 78% compared to 16%, respectively, in the year 2022. Further, bacterial conjunctivitis was higher at 71% among children, while viral conjunctivitis accounted for 16%. Therefore, the rising prevalence of conjunctivitis cases drives the demand for the conjunctivitis treatment market.

Key Industry Players

Major companies operating in the conjunctivitis treatment market report are Pfizer Inc., Johnson and Johnson, AbbVie Inc., Novartis AG, Sanofi SA, Boehringer Ingelheim, Viatris Inc., Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Inc., Bausch Health Companies Inc, Santen Pharmaceuticals Co. Ltd, Lupin Limited, Allergan PLC, Alembic Pharmaceuticals Ltd, Akorn Inc., Micro Labs Ltd., Indoco Remedies Ltd., Mankind Pharma Ltd., AFT pharmaceuticals Limited, Ocular Therapeutics Inc., Sirion Therapeutics Inc., Jabs Biotech Pvt. Ltd., Atopix Therapeutics Ltd., JAWA Pharmaceuticals Pvt. Ltd., Eyevance Pharmaceuticals LLC, NicOx SA

The conjunctivitis treatment market report table of contents includes:

1. Executive Summary

2. Conjunctivitis Treatment Market Characteristics

3. Conjunctivitis Treatment Market Trends And Strategies

4. Conjunctivitis Treatment Market – Macro Economic Scenario

5. Global Conjunctivitis Treatment Market Size and Growth

…

32. Global Conjunctivitis Treatment Market Competitive Benchmarking

33. Global Conjunctivitis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Conjunctivitis Treatment Market

35. Conjunctivitis Treatment Market Future Outlook and Potential Analysis

36. Appendix